Page last updated: 2024-08-24

topotecan and Liver Diseases

topotecan has been researched along with Liver Diseases in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (50.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eklund, JW; Mulcahy, MF; Trifilio, S	1
Chen, Z; Feng, YL; Gu, W; Li, B; Ling, CQ	1
Bowling, K; Brubaker, A; Chen, TL; Donehower, RC; Ettinger, D; Forastiere, A; Grochow, LB; Ignacio, V; Lubejko, B; O'Reilly, S; Rowinsky, E; Sartorius, S; Slichenmyer, W; Smith, J	1
Beijnen, JH; Herben, VM; ten Bokkel Huinink, WW	1

Reviews

2 review(s) available for topotecan and Liver Diseases

Article	Year
Chemotherapy dosing in the setting of liver dysfunction. Oncology (Williston Park, N.Y.), 2005, Volume: 19, Issue:8 Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Gemcitabine; Humans; Liver; Liver Diseases; Liver Function Tests; Male; Maximum Tolerated Dose; Neoplasms; Randomized Controlled Trials as Topic; Risk Assessment; Topotecan	2005
Clinical pharmacokinetics of topotecan. Clinical pharmacokinetics, 1996, Volume: 31, Issue:2 Topics: Antineoplastic Agents; Camptothecin; Enzyme Inhibitors; Half-Life; Humans; Kidney Diseases; Liver Diseases; Metabolic Clearance Rate; Topoisomerase I Inhibitors; Topotecan	1996

Article

Year

Chemotherapy dosing in the setting of liver dysfunction.

Oncology (Williston Park, N.Y.), 2005, Volume: 19, Issue:8

Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Gemcitabine; Humans; Liver; Liver Diseases; Liver Function Tests; Male; Maximum Tolerated Dose; Neoplasms; Randomized Controlled Trials as Topic; Risk Assessment; Topotecan

2005

Clinical pharmacokinetics of topotecan.

Clinical pharmacokinetics, 1996, Volume: 31, Issue:2

Topics: Antineoplastic Agents; Camptothecin; Enzyme Inhibitors; Half-Life; Humans; Kidney Diseases; Liver Diseases; Metabolic Clearance Rate; Topoisomerase I Inhibitors; Topotecan

1996

Trials

2 trial(s) available for topotecan and Liver Diseases

Article	Year
[Ginsenosides and dexamethasone in managing the liver injury and renal function after transcatheter arterial chemoembolization for hepatic carcinoma patient]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2006, Volume: 28, Issue:11 Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; Blood Urea Nitrogen; Chemoembolization, Therapeutic; Creatinine; Dexamethasone; Drug Therapy, Combination; Epirubicin; Female; Fluorouracil; Ginsenosides; Glucocorticoids; Humans; Iodized Oil; Kidney; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Topotecan	2006
Phase I and pharmacologic studies of topotecan in patients with impaired hepatic function. Journal of the National Cancer Institute, 1996, Jun-19, Volume: 88, Issue:12 Topics: Adult; Aged; Antineoplastic Agents; Camptothecin; Drug Administration Schedule; Drug Screening Assays, Antitumor; Female; Humans; Linear Models; Liver; Liver Diseases; Liver Function Tests; Male; Middle Aged; Topotecan	1996

Article

Year

[Ginsenosides and dexamethasone in managing the liver injury and renal function after transcatheter arterial chemoembolization for hepatic carcinoma patient].

Zhonghua zhong liu za zhi [Chinese journal of oncology], 2006, Volume: 28, Issue:11

Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; Blood Urea Nitrogen; Chemoembolization, Therapeutic; Creatinine; Dexamethasone; Drug Therapy, Combination; Epirubicin; Female; Fluorouracil; Ginsenosides; Glucocorticoids; Humans; Iodized Oil; Kidney; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Topotecan

2006

Phase I and pharmacologic studies of topotecan in patients with impaired hepatic function.

Journal of the National Cancer Institute, 1996, Jun-19, Volume: 88, Issue:12

Topics: Adult; Aged; Antineoplastic Agents; Camptothecin; Drug Administration Schedule; Drug Screening Assays, Antitumor; Female; Humans; Linear Models; Liver; Liver Diseases; Liver Function Tests; Male; Middle Aged; Topotecan

1996